October 2011 | OncologyLive

Tumoral CRP Levels Correlate With Survival in Renal Cell Carcinoma

November 30, 2011

The level of C-reactive protein (CRP) expressed in the tumor specimens of patients with renal cell carcinoma (RCC) may serve as a widely available biomarker for postoperative prognosis of localized disease.

5 Questions for Josep Tabernero, MD

November 17, 2011

Josep Tabernero, MD, is actively involved in clinical research with molecular targeted therapies, with a focus on EGFR-family and PI3K-Akt-mTOR pathway inhibitors, in phase II and III studies with new chemotherapy agents in gastrointestinal tumors.